| [1] | 王世真. 我国核医学的现状与展望[J]. 核技术, 1988, 11: 9-16.
|
| [2] | 刘伯里, 金昱泰. 中国体内放射性药物的现状与展望[J]. 核化学与放射化学, 1998, 11: 229-235.
|
| [3] | 马崇智. 体内放射性药物的发展[J]. 同位素, 1992, 5: 167-192.
|
| [4] | Liu Y, Wu C. Radiolabelling of monoclonal antibodies with metal chelates[J]. Pure Appl Chem, 1991, 64: 427-463.
|
| [5] | Wang X, Wu Y, Wang Y, et al. Radiopharmaceutical chemistry in Peking University[J]. J Nucl Radiochem Sci, 2000, 1: 15.
|
| [6] | 罗顺忠, 蒋树斌, 魏洪源. 国内放射性药物研究现状[J]. 高科技与产业化, 2006, (4): 52-53.
|
| [7] | Xia J, Wang Y, Yu J, et al. Synthesis, in vitro and in vivo behavior of 188Re(I)-tricarbonyl complexes for the future functionalization of biomolecules[J]. J Radioanal Nucl Chem, 2008, 275: 325-330.
|
| [8] | 张锦荣, 罗志福. 中国放射性同位素技术与应用进展[J]. 中国工程科学, 2008, 10: 61-69.
|
| [9] | Luo Z. The production of medical radioisotopes and radiopharmaceuticals and their applications in PR China[C]//Seventh Japan-China Joint Seminar on Radiopharmaceutical Chemistry (JCSRC 2007). Kyoto, Japan：Kyoto University， 2007: 25-33.
|
| [10] | 张锦明, 田嘉禾. 国内正电子放射性药物发展现状简介[J]. 同位素, 2006, 19: 240-245.
|
| [11] | 褚泰伟, 张华北, 张俊波, 等. 放射性药物面临的机遇与挑战[J]. 核化学与放射化学, 2009, 31(增刊): 58-63.
|
| [12] | Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET[J]. Chem Rev, 2008, 108: 1 501-1 516.
|
| [13] | 吴晨希，朱朝晖，李方，等. 分子影像：转化医学的重要工具和主要路径[J]. 生物物理学报，2011，27：327-334.
|
| [14] | Bayele HK, Chiti A, Colina R, et al. Isotopic biomarker discovery and application in translational medicine[J]. Drug Discov Today, 2010, 15: 127-137.
|
| [15] | International Atomic Energy Agency. Nuclear Technology Review 2010 [R/OL]. Vienna: IAEA, 2010: 50（2011-03-20）.
|
| [16] | Molecular Imaging and Contrast Agent Database (MICAD) [database online]. Bethesda (MD): National Library of Medicine (US) [EB/OL] [2011-04-11].
|
| [17] | Coenen HH, Elsinga PH, Iwata R, et al. Fluorine-18 radiopharmaceuticals beyond [18F]FDG for use in oncology and neurosciences[J]. Nucl Med Biol, 2010, 37: 727-740.
|
| [18] | Wadsak W, Mitterhauser M. Basic and principles of radiopharmaceuticals for PET/CT[J]. Eur J Radiology, 2010, 73: 461-469.
|
| [19] | 张锦明，田嘉禾. 11C标记的放射性药物在PET-CT肿瘤诊断上的应用[J]. 国外医学：放射医学核医学分册，2005，29：232-237.
|
| [20] | 李彪，朱承谟. 正电子放射性药物的临床应用与进展[J]. 诊断学理论与实践，2005，4：93-96.
|
| [21] | 王荣福，刘红洁，张春丽. PET受体显像的研究应用进展[J]. 中国医学影像技术，2006，22：1 599-1 603.
|
| [22] | 彭添兴，吴华. 18F-氟脱氧葡萄糖以外新型PET肿瘤显像剂[J]. 国际放射医学核医学杂志，2007，31：9-12.
|
| [23] | Li Z, Conti PS. Radiopharmaceutical chemistry in positron emission tomography[J]. Adv Drug Delivery reviews, 2010, 62: 1 031-1 051.
|
| [24] | Miller PW, Long NG, Vilar R, et al. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography[J]. Angew Chem Int Ed, 2008, 47: 8 998-9 033.
|
| [25] | Van Dort ME, Rehemtulla A, Ross BD. PET and SPECT imaging of tumor biology: new approaches towards oncology drug discovery and development[J]. Current Computer-Aided Drug Design, 2008, 4: 46-53.
|
| [26] | Kumar R, Lal N. PET in anti-cancer drug development and therapy[J]. Recent Pat Anti-Canc, 2007, 2: 259-263.
|
| [27] | Sugiyama Y. Effective use of microdosing and positron emission tomographt (PET) studies on new drug discovery and development[J]. Drug Metab Pharmacokinet, 2009, 24: 127-129.
|
| [28] | Koehler L, Gagnon K, McQuarrie S, et al. Iodine-124: a promising positron emitter for organic PET chemistry[J]. Molecules, 2010, 15: 2 686-2 718.
|
| [29] | Smith SV. Molecular imaging with copper-64[J]. J Inorg Biochem, 2004, 98: 1 874-1 901.
|
| [30] | Wadas TJ, Wong EH, Weisman GR, et al. Copper chelation chemistry and its role in copper radiopharmaceuticals[J]. Current Pharm Design, 2007, 13: 3-16.
|
| [31] | Anderson CJ, Ferdani R. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research[J]. Cancer Biotherapy and Radiopharmaceuticals, 2009, 24: 379-393.
|
| [32] | Maecke HR, Hofmann M, Haberkorn U. 68Ga-labeled peptides in tumor imaging[J]. J Nucl Med, 2005, 46: 172S-178S.
|
| [33] | Srirajaskanthan R, Kayani I, Quigley AM, et al. The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy[J]. J Nucl Med, 2010, 51: 875-882.
|
| [34] | Virgolini I, Ambrosini V, Bomanji JB, et al. Procedure guidelines for PET/CT tumor imaging with 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DO-TA-TATE[J]. Eur J Nucl Med Mol Imaging, 2010, 37: 2 004-2 010.
|
| [35] | Zolle I， Eds. Technetium-99m pharmaceuticals: preparation and quality control in nuclear medicine[M]. Springer Berlin Heidelberg, 2007.
|
| [36] | Technetium-99m radiopharmaceuticals: manufacture of Kits[R]. IAEA Technical Reports. Series No. 466. Vienna: IAEA, 2008.
|
| [37] | Domenico GDI, Zavattini G. Chapter 4 advances in SPECT instrumentation (including animal scanners)[C]//International Atomic Energy Agency. Technetium-99m Radiopharmaceuticals: status and trends. IAEA Radioisotopes and Radiopharmaceuticals. Series No. 1. Vienna: IAEA, 2009: 57-90.
|
| [38] | Bach-Gansmo T, Danielsson R, Saracco A, et al. Integrin receptor imaging of breast cancer: A proof-of-concept study to evaluate Tc-99m-NC100692[J]. J Nucl Med, 2006, 47: 1 434-1 439.
|
| [39] | Axelsson R, BachGansmo T, Castell-Conesa J, et al. An open-label, multicenter, phase 2a study to assess the feasibility of imaging metastases in late-stage cancer patients with the a alpha(v)beta(3)-selective angiogenesis imaging agent Tc-99m-NC100692[J]. Acta Radiol, 2010, 51: 40-46.
|
| [40] | Hao GY, Zang JY, Zhu L,et al. Synthesis, separation and biodistribution of 99Tcm-CO-MIBI complex[J]. J Label Compd Radiopharm, 2004, 47: 513-521.
|
| [41] | 王金城，刘伯里，米宏志，等. 心肌显像剂[99Tcm(CO3(MIBI3]+和99Tcm-MIBI药理实验对比研究[J]. 中华核医学杂志，2002，22：231-232.
|
| [42] | Liu G, Liu B. Synthesis of a new polyaminopolycarboxybic acid (BPHA) and labeling with 99Tcm [J]. J labelled Compds Radiopharm, 1998, XL1: 97-104.
|
| [43] | Miao Y, Liu B. Synthesis of new N2S ligands, preparation of 99Tcm complexes and their preliminary biodistribution in mice[J]. J labelled Compds Radiopharm, 1999, 42: 629-640.
|
| [44] | Zhang J, Wang X, Lu G, et al. Synthesis, characterization and biodistribution of a 99Tcm nitrido complex as a potential brain perfusion imaging agent[J]. J Labelled Compd Radiopharm, 2000, 43: 693-700.
|
| [45] | Zhang J, Guo H, Zhang S, et al. Synthesis and biodistribution of a novel 99TcmN complex of ciprofloxacin dithiocarbamate as a potential agent for infection imaging[J]. Bioorg Med Chem Lett, 2008, 18: 5 168-5 170.
|
| [46] | Zhang J, Zhang S, Guo H, et al. Synthesis and biological evaluation of a novel 99Tcm (CO3 complex of ciprofloxacin dithiocarbamate as a potential agent to target infection[J]. Bioorg Med Chem Lett, 2010, 20: 3 781-3 784.
|
| [47] | Zhang S, Zhang W, Wang Y, et al. Synthesis and biodistribution of a novel 99TcmN complex of norfloxacin dithiocarbamate as a potential agent for bacterial infection imaging[J]. Bioconj Chem, 2011, 22: 369-375.
|
| [48] | 毛一雷，董一女，杨文江，等. 肝细胞受体显像剂的制备及其药盒化[J]. 同位素，2008，21：88-94,128.
|
| [49] | Yang W, Mou T, Shao G, et al. Copolymer-based hepatocyte asialoglycoprotein receptor targeting agent for SPECT [J]. J Nucl Med, 2011, 52: 978-985.
|
| [50] | Wei Y, Liu BL, Kung HF. Quantitative study of the structure-stability relationship of Tc complexes[J]. Appl Radiat Isot, 1990, 41: 763-771.
|
| [51] | Kung HF, Liu Boli, Wei Y, et al. Quantitative study of the structure-stability relationship of technetium oxide [TcVO(Ⅲ)] complexes[J]. Appl Radiat Isot, 1990, 41: 773-781.
|
| [52] | Liu Boli, Jia Hongmei. Quantitative study of brain retention mechanism of 99TcmO chelates[J]. J Labelled Compds Radiopharm, 1995, 37: 788.
|
| [53] | 孟昭兴，贾红梅，杨文，等. 锝化学研究Ⅹ: 99Tcm标记的N2S2类脑显像剂构效关系的研究[J]. 核化学与放射化学，1998，20（1）：14-19.
|
| [54] | Jia H, Ma X, Wang C, et al. Solvent effects on brain uptake of isomers of 99mTc-brain radiopharmaceuticals[J]. Chinese Science Bulletin, 2002, 47(21): 1 786-1 791.
|
| [55] | Jia HM, Fang DC, Feng Y, et al. The interconversion mechanism between TcO3+ and TcO2+ core of 99Tcm labeled amine-oxime(AO)complexes[J]. Theoretical Chemistry Account, 2008, 121: 271-278.
|
| [56] | Yu L, Fang DC, Ren HY, et al. Ligand exchange mechanism of fac[99Tcm(CO3(H2O3]+ complexes for 99Tcm-CO-MIBI radiopharmaceuticals[C]// Technetium and Other Radiometals in Chemistry and Medicine. Mazzi U, Eckelman WC, Volkert WA, Eds. Padova, Italy: SGE Editoriali, 2011: 339-340.
|
| [57] | 邓新荣，刘飞，罗志福. 123I放射性药物简介[J]. 中华核医学杂志，2007，27：189-190.
|
| [58] | Yamashina S, Yamazaki J. Neuronal imaging using SPECT[J]. Eur J Nucl Med Mol Imaging, 2007, 34: 939-950.
|
| [59] | Ross SA, Seibyl JP. Research applications of selected 123I-labeled neuroreceptor SPECT imaging ligands[J]. J Nucl Med Technol, 2004, 32: 209-214.
|
| [60] | Varrone A, halldin C. Molecular imaging of the dopamine transporter[J]. J Nucl Med, 2010, 51: 1 331-1 334.
|
| [61] | Schottelius M, Wester HJ. Molecular imaging targeting peptide receptors[J]. Methods, 2009, 48: 161-177.
|
| [62] | Tweedle MF. Peptide-targeted diagnostics and radiotherapeutics[J]. Accounts of Chemical Research, 2009, 42: 958-968.
|
| [63] | Correia JDG, Paulo A, Raposinso PD, et al. Radiometallated peptides for molecular imaging and targeted therapy[J]. Dalton Trans, 2011, 40: 6 144-6 167.
|
| [64] | International Atomic Energy Agency. Comparative evaluation of therapeutic radiopharmaceuticals[R]. IAEA technical reports. Series No. 458. Vienna: IAEA, 2007.
|
| [65] | 段润卿，刘兴党. 177Lu标记放射性药物研究新进展[J]. 中华核医学杂志，2010，30（3）：139-141.
|
| [66] | 邓新荣，李洪玉，叶肇云，等.177Lu-EDTMP和177Lu-DOTMP的制备及其生物分布[J]. 同位素，2009，22（2）：71-75.
|
| [67] | 李洪玉，梁积新，向学琴，等. 177Lu-EDTMP的药盒法制备、大鼠体内生物分布及显像[J].同位素，2010，23（2）：65-70.
|
| [68] | 陈永祥，陈家华. 放射性粒子近距离治疗肿瘤研究进展[J]. 河北医药，2006，28：1 093-1 094.
|
| [69] | 李忠勇，高惠波，金小海，等. 近距离治疗肿瘤的放射性粒子研究进展[J]. 同位素，2011, 24：118-123.
|
| [70] | 马俊刚，王阁，倪蓉晖，等. 125I放射性粒子植入联合三维适形放疗治疗局部非小细胞肺癌的疗效[J]. 现代肿瘤医学，2010，18：2 390-2 392.
|
| [71] | 曹贵文，崔新江，宁厚法，等. 125I放射性粒子治疗高位胆管癌的临床研究[J]. 中国介入放射学，2009，3（1）：37-40.
|
| [72] | 曹贵文，崔新江，宁厚法，等. 125I放射性粒子永久性植入术用于32例高位胆管癌效果观察[J]. 山东医药，2010，50：92-93.
|
| [73] | 张云峰，曹贵文，崔新江，等. TACE与125I放射性粒子植入序贯治疗HCC的临床研究[J]. 医学影像学杂志，2010，20：1 377-1 380.
|
| [74] | 张惠洁，郭卫东. 放射性粒子组织间插植治疗恶性肿瘤[J]. 疾病监测与控制杂志，2008，2：156-157.
|
| [75] | 曾明喜. 吉西他滨联合125I放射性粒子植入治疗老年非小细胞肺癌的临床分析[J]. 中国医学创新，2010，7：90-91.
|
| [76] | Oyen WJG, Bodei L, Giammarile F, et al. Targeted therapy in nuclear medicine-current status and future prospects[J]. Annals of Oncology, 2007, 18: 1 782-1 792.
|
| [77] | Srivastava SC. Theragnostic radiometals: getting closer to personalized medicine[C]// Technetium and Other Radiometals in Chemistry and Medicine. Mazzi U, Eckelman WC, Volkert WA, Eds. Padova, Italy: SGE Editoriali, 2011: XXXV-XLIV.
|
| [78] | Robertson R, Germanos MS, Li C, et al. Optical imaging of Cerenkov light generation from positron-emitting radiotracers[J]. Phys Med Biol, 2009, 54: N355-365.
|
| [79] | Liu H, Ren G, Miao Z, et al. Molecular optical imaging with radioactive probes[J]. Plos One, 2010, 5: e9 470.
|
| [80] | Hu Z, Liang J, Yang W, et al. Experimental Cerenkov luminescence tomography of the mouse model with SPECT imaging validation[J]. Optics Express, 2010, 18: 24 441-24 450.
|
| [81] | Alberto R. Chapter 17 Future trends in the development of technetium radiopharmaceuticals[C]//International Atomic Energy Agency. Technetium-99m Radiopharmaceuticals: status and trends. IAEA Radioisotopes and Radiopharmaceuticals. Series No. 1. Vienna: IAEA, 2009: 347-358.
|
